AMD Advanced Micro Devices Inc.

AMD EPYC™ Processors Accelerate High Performance Computing Capability in Perlmutter Supercomputer

AMD EPYC™ Processors Accelerate High Performance Computing Capability in Perlmutter Supercomputer

— New system will enable next-gen research on clean energy, climate and more for the National Energy Research Scientific Computing Center —

SANTA CLARA, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: AMD) today joined the National Energy Research Scientific Computing Center (NERSC), Lawrence Berkeley National Laboratory (Berkeley Lab) and others in unveiling the new Perlmutter supercomputer powered by .

The new supercomputer at Berkeley Lab will provide four times the computational power currently available at NERSC, making it among the fastest supercomputers in the world for scientific simulation, data analysis and artificial intelligence (AI). In development since 2019, the new system takes advantage of the industry-leading HPC workload performance1 offered by the new 3rd Gen AMD EPYC processors to facilitate faster and advanced research in climate, clean energy, semiconductors, microelectronics and quantum information science.

“AMD is extremely proud to work with our strategic partners to push the boundaries of HPC in areas including scientific and environmental research, medical advancements and artificial intelligence,” said Forrest Norrod, senior vice president and general manager, Data Center and Embedded Solutions Business Group. “The new Perlmutter supercomputer from NERSC, will drive the next wave of critical discoveries that help to solve the world’s biggest challenges.”

“Our work with key partners like AMD enables us to significantly increase our computing power and broaden our spectrum of scientific capabilities,” said NERSC Director Sudip Dosanjh. “Perlmutter will enable a larger range of applications than previous NERSC systems and is the first NERSC supercomputer designed from the start to meet the needs of both simulation and data analysis."

Perlmutter, named in honor of Nobel Prize-winning astrophysicist Saul Perlmutter, is being delivered in two phases. Phase 1 is now being deployed and features 1,536 nodes, each with one AMD EPYC 7763 processor and four NVIDIA NVlink-connected A100 Tensor Core GPUs. Phase 1 also includes a 35 PB all-flash Lustre file system that will provide very high-bandwidth storage. Expected later this year, phase 2 will add another 3,072 CPU-only nodes, each with two AMD EPYC 7763 processors and 512 GB of memory per node.

Supporting Resources

  • Learn more about AMD EPYC Processors
  • See more about 
  • Read more about
  • See demos, videos and more about the
  • Follow AMD on

About AMD

For more than 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies ― the building blocks for gaming, immersive platforms and the datacenter. Hundreds of millions of consumers, leading Fortune 500 businesses and cutting-edge scientific research facilities around the world rely on AMD technology daily to improve how they live, work and play. AMD employees around the world are focused on building great products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) , , and pages.

AMD, the AMD Arrow logo and EPYC, are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners.

1 MLN-086: Based on SPECrate®_fp_base of 4/14/2021, 2x AMD EPYC™ 7763 scored 651 ; 2x Intel® Xeon® Platinum 8380 scored 472 . SPEC®, SPECrate® and SPEC CPU® are registered trademarks of the Standard Performance Evaluation Corporation. See for more information.

 



Contact:
Aaron Grabein
AMD Communications
(512) 602-8950
 
 
Laura Graves
AMD Investor Relations
(408) 749-5467
 
EN
27/05/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Advanced Micro Devices Inc.

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NKTR NEKTAR THERAPEUTICS
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
ACRS ACLARIS THERAPEUTICS INC.
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
OVID OVID THERAPEUTICS
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ORIC KEROS THERAPEUTICS
ZNTL ORIC PHARMACEUTICALS
BEAM ZENTALIS PHARMACEUTICALS
LRMR BEAM THERAPEUTICS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
SANA VIRIDIAN THERAPEUTICS INC
PLTK SANA BIOTECHNOLOGY
RBLX PLAYTIKA HOLDING
DAWN ROBLOX
STX DAY ONE BIOPHARMACEUTICALS INC
APP SEAGATE TECHNOLOGY HLDGS PLC
GFS APPLOVIN CORP
GMTX GLOBALFOUNDRIES INC
TYRA GEMINI THERAPEUTICS INC
PEPG TYRA BIOSCIENCES INC
EWTX PEPGEN INC
SLDB EDGEWISE THERAPEUTICS INC
DDI SOLID BIOSCIENCES INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
EMBRAC B APOGEE THERAPEUTICS INC
DNTH EMBRACER GROUP AB
ORKA DIANTHUS THERAPEUTICS INC
BCAX ORUKA THERAPEUTICS INC
ZBIO BICARA THERAPEUTICS INC.
TLX ZENAS BIOPHARMA INC.
MAZE TELIX PHARMACEUTICALS LIMITED
JBIO MAZE THERAPEUTICS INC
IMA JADE BIOSCIENCES INC
IMAGENEBIO INC.
Pierre FerraguÊ
  • Pierre FerraguÊ

The Tech Infrastructure Quarterly Bible 4Q25

​​​​We publish today our comprehensive quarterly bible: 243 pages of detailed analyses on what happened in the last 3 months, and how we interpret it, in light of our current convictions. The first section acts as a PM summary, outlining our key findings, and latest thoughts on the semi cycle, in 6 slides:

ResearchPool Subscriptions

Get the most out of your insights

Get in touch